Related references
Note: Only part of the references are listed.Coiled-coil irregularities of the M1 protein structure promote M1-fibrinogen interaction and influence group A Streptococcus host cell interactions and virulence
Satoshi Uchiyama et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2013)
Quantitative reagent-free detection of fibrinogen levels in human blood plasma using Raman spectroscopy
Kelvin W. C. Poon et al.
ANALYST (2012)
Invasive Group A Streptococcal Disease
Andrew C. Steer et al.
DRUGS (2012)
Streptococcal M1 protein constructs a pathological host fibrinogen network
Pauline Macheboeuf et al.
NATURE (2011)
Molecular insight into invasive group A streptococcal disease
Jason N. Cole et al.
NATURE REVIEWS MICROBIOLOGY (2011)
The M protein of group A Streptococcus is a key virulence factor and a clinically relevant strain identification marker
David Metzgar et al.
VIRULENCE (2011)
Streptococcal M proteins and their role as virulence determinants
Sonja Oehmcke et al.
CLINICA CHIMICA ACTA (2010)
Genetic Switch to Hypervirulence Reduces Colonization Phenotypes of the Globally Disseminated Group A Streptococcus M1T1 Clone
Andrew Hollands et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Group A streptococcal vaccines: facts versus fantasy
Andrew C. Steer et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2009)
The early interferon response of nasal-associated lymphoid tissue to Streptococcus pyogenes infection
Kendra A. Hyland et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2009)
M1 Protein Allows Group A Streptococcal Survival in Phagocyte Extracellular Traps through Cathelicidin Inhibition
Xavier Lauth et al.
JOURNAL OF INNATE IMMUNITY (2009)
Global emm type distribution of group A streptococci: systematic review and implications for vaccine development
Andrew C. Steer et al.
LANCET INFECTIOUS DISEASES (2009)
Human pathogenic streptococcal proteomics and vaccine development
Jason N. Cole et al.
PROTEOMICS CLINICAL APPLICATIONS (2008)
Coiled-coil irregularities and instabilities in group A Streptococcus M1 are required for virulence
Case McNamara et al.
SCIENCE (2008)
Rise and persistence of global M1T1 clone of Streptococcus pyogenes
Ramy K. Aziz et al.
EMERGING INFECTIOUS DISEASES (2008)
Fibrinogen is localized on dark zone follicular dendritic cells in vivo and enhances the proliferation and survival of a centroblastic cell line in vitro
Eric A. Lefevre et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
DNase Sda1 provides selection pressure for a switch to invasive group A streptococcal infection
Mark J. Walker et al.
NATURE MEDICINE (2007)
New understanding of the group A Streptococcus pathogenesis cycle
Anne H. Tart et al.
TRENDS IN MICROBIOLOGY (2007)
Pili mediate specific adhesion of Streptococcus pyogenes to human tonsil and skin
Emily L. Abbot et al.
CELLULAR MICROBIOLOGY (2007)
Serum opacity factor promotes group A streptococcal epithelial cell invasion and virulence
Anjuli M. Timmer et al.
MOLECULAR MICROBIOLOGY (2006)
Trigger for group A streptococcal M1T1 invasive disease
Jason N. Cole et al.
FASEB JOURNAL (2006)
Human C4b-binding protein, structural basis for interaction with streptococcal M protein, a major bacterial virulence factor
HT Jenkins et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Anti-phagocytic mechanisms of Streptococcus pyogenes:: binding of fibrinogen to M-related protein
HS Courtney et al.
MOLECULAR MICROBIOLOGY (2006)
Binding of human plasma proteins to Streptococcus pyogenes M protein determines the location of opsonic and non-opsonic epitopes
C Sandin et al.
MOLECULAR MICROBIOLOGY (2006)
Genome-wide analysis of group A streptococci reveals a mutation that modulates global phenotype and disease specificity
Paul Sumby et al.
PLOS PATHOGENS (2006)
The global burden of group A streptococcal diseases
JR Carapetis et al.
LANCET INFECTIOUS DISEASES (2005)
Human fibrinogen bound to Streptococcus pyogenes M protein inhibits complement deposition via the classical pathway
F Carlsson et al.
MOLECULAR MICROBIOLOGY (2005)
M protein, a classical bacterial virulence determinant, forms complexes with fibrinogen that induce vascular leakage
H Herwald et al.
CELL (2004)
Group A streptococcal pharyngitis serotype surveillance in North America, 2000-2002
ST Shulman et al.
CLINICAL INFECTIOUS DISEASES (2004)
Invasive M1T1 group A Streptococcus undergoes a phase-shift in vivo to prevent proteolytic degradation of multiple virulence factors by SpeB
RK Aziz et al.
MOLECULAR MICROBIOLOGY (2004)
Membranous cells in nasal-associated lymphoid tissue: A portal of entry for the respiratory mucosal pathogen group A streptococcus
HS Park et al.
JOURNAL OF IMMUNOLOGY (2003)
Selective modulation of superantigen-induced responses by streptococcal cysteine protease
RG Kansal et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Molecular mechanisms of adhesion, colonization, and invasion of group A streptococci
HS Courtney et al.
ANNALS OF MEDICINE (2002)
Spontaneous mutations in the CsrRS two-component regulatory system of Streptococcus pyogenes result in enhanced virulence in a murine model of skin and soft tissue infection
NC Engleberg et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Inverse relation between disease severity and expression of the streptococcal cysteine protease, SpeB, among clonal M1T1 isolates recovered from invasive group A streptococcal infection cases
RG Kansal et al.
INFECTION AND IMMUNITY (2000)
Pathogenesis of group A streptococcal infections
MW Cunningham
CLINICAL MICROBIOLOGY REVIEWS (2000)
Genetic relatedness and superantigen expression in group A streptococcus serotype MZ isolates from patients with severe and nonsevere invasive diseases
S Chatellier et al.
INFECTION AND IMMUNITY (2000)
Human keratinocytes that express hTERT and also bypass a p16INK4a-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics
MA Dickson et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
A role for the fibrinogen-binding regions of streptococcal M proteins in phagocytosis resistance
U Ringdahl et al.
MOLECULAR MICROBIOLOGY (2000)